9467311000001101: Lysodren 500mg tablets (HRA Pharma UK & Ireland Ltd) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Lysodren 500mg tablets (HRA Pharma UK & Ireland Ltd)
\UK product\Virtual medicinal product\Product containing precisely mitotane 500 milligram/1 each conventional release oral tablet\Lysodren 500mg tablets (HRA Pharma UK & Ireland Ltd)
\UK product\Virtual therapeutic moiety\Mitotane\Product containing only mitotane in oral dose form (medicinal product form)\Product containing precisely mitotane 500 milligram/1 each conventional release oral tablet\Lysodren 500mg tablets (HRA Pharma UK & Ireland Ltd)
\UK product\Virtual therapeutic moiety\Mitotane\Product containing precisely mitotane 500 milligram/1 each conventional release oral tablet\Lysodren 500mg tablets (HRA Pharma UK & Ireland Ltd)
\UK product\Trade family\Lysodren\Lysodren 500mg tablets (HRA Pharma UK & Ireland Ltd)

\Medicinal product\Medicinal product categorized by structure\Product containing chlorine and/or chlorine compound (product)\Product containing chlorinated hydrocarbon\Product containing mitotane\Mitotane\Product containing only mitotane in oral dose form (medicinal product form)\Product containing precisely mitotane 500 milligram/1 each conventional release oral tablet\Lysodren 500mg tablets (HRA Pharma UK & Ireland Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing chlorine and/or chlorine compound (product)\Product containing chlorinated hydrocarbon\Product containing mitotane\Mitotane\Product containing precisely mitotane 500 milligram/1 each conventional release oral tablet\Lysodren 500mg tablets (HRA Pharma UK & Ireland Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing chlorine and/or chlorine compound (product)\Product containing chlorinated hydrocarbon\Product containing mitotane\Product containing mitotane in oral dose form (medicinal product form)\Product containing only mitotane in oral dose form (medicinal product form)\Product containing precisely mitotane 500 milligram/1 each conventional release oral tablet\Lysodren 500mg tablets (HRA Pharma UK & Ireland Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing halogenated hydrocarbon\Product containing chlorinated hydrocarbon\Product containing mitotane\Mitotane\Product containing only mitotane in oral dose form (medicinal product form)\Product containing precisely mitotane 500 milligram/1 each conventional release oral tablet\Lysodren 500mg tablets (HRA Pharma UK & Ireland Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing halogenated hydrocarbon\Product containing chlorinated hydrocarbon\Product containing mitotane\Mitotane\Product containing precisely mitotane 500 milligram/1 each conventional release oral tablet\Lysodren 500mg tablets (HRA Pharma UK & Ireland Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing halogenated hydrocarbon\Product containing chlorinated hydrocarbon\Product containing mitotane\Product containing mitotane in oral dose form (medicinal product form)\Product containing only mitotane in oral dose form (medicinal product form)\Product containing precisely mitotane 500 milligram/1 each conventional release oral tablet\Lysodren 500mg tablets (HRA Pharma UK & Ireland Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Product containing mitotane\Mitotane\Product containing only mitotane in oral dose form (medicinal product form)\Product containing precisely mitotane 500 milligram/1 each conventional release oral tablet\Lysodren 500mg tablets (HRA Pharma UK & Ireland Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Product containing mitotane\Mitotane\Product containing precisely mitotane 500 milligram/1 each conventional release oral tablet\Lysodren 500mg tablets (HRA Pharma UK & Ireland Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Product containing mitotane\Product containing mitotane in oral dose form (medicinal product form)\Product containing only mitotane in oral dose form (medicinal product form)\Product containing precisely mitotane 500 milligram/1 each conventional release oral tablet\Lysodren 500mg tablets (HRA Pharma UK & Ireland Ltd)
\Medicinal product\Product manufactured as oral dose form\Product containing mitotane in oral dose form (medicinal product form)\Product containing only mitotane in oral dose form (medicinal product form)\Product containing precisely mitotane 500 milligram/1 each conventional release oral tablet\Lysodren 500mg tablets (HRA Pharma UK & Ireland Ltd)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

133971000001116 Lysodren 500mg tablets (HRA Pharma UK & Ireland Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
133981000001119 Lysodren 500mg tablets (HRA Pharma UK & Ireland Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
30922501000001118 Lysodren 500mg tablets (Laboratoire HRA Pharma) (product) en Fully specified name Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module
30922601000001119 Lysodren 500mg tablets (Laboratoire HRA Pharma) en Synonym Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module
56833701000001110 Lysodren 500mg tablets (HRA Pharma UK Ltd) en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Lysodren 500mg tablets (HRA Pharma UK & Ireland Ltd)	Is a	Product containing precisely mitotane 500 milligram/1 each conventional release oral tablet	true	Inferred relationship	Existential restriction modifier
Lysodren 500mg tablets (HRA Pharma UK & Ireland Ltd)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none	true	Inferred relationship	Existential restriction modifier
Lysodren 500mg tablets (HRA Pharma UK & Ireland Ltd)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Lysodren 500mg tablets (HRA Pharma UK & Ireland Ltd)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Lysodren 500mg tablets (HRA Pharma UK & Ireland Ltd)	Has active ingredient	Mitotane	false	Inferred relationship	Existential restriction modifier
Lysodren 500mg tablets (HRA Pharma UK & Ireland Ltd)	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Lysodren 500mg tablets (HRA Pharma UK & Ireland Ltd)	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier
Lysodren 500mg tablets (HRA Pharma UK & Ireland Ltd)	Has manufactured dose form	Conventional release oral tablet	true	Inferred relationship	Existential restriction modifier
Lysodren 500mg tablets (HRA Pharma UK & Ireland Ltd)	Is a	Lysodren	true	Inferred relationship	Existential restriction modifier
Lysodren 500mg tablets (HRA Pharma UK & Ireland Ltd)	Has specific active ingredient	Mitotane	true	Inferred relationship	Existential restriction modifier
Lysodren 500mg tablets (HRA Pharma UK & Ireland Ltd)	Has dispensed dose form	Tablet	true	Inferred relationship	Existential restriction modifier
Lysodren 500mg tablets (HRA Pharma UK & Ireland Ltd)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Lysodren 500mg tablets (HRA Pharma UK & Ireland Ltd) 100 tablet	Is pack of	False	Lysodren 500mg tablets (HRA Pharma UK & Ireland Ltd)	Inferred relationship	Existential restriction modifier
Lysodren 500mg tablets (HRA Pharma UK & Ireland Ltd) 100 tablet	Has AMP	True	Lysodren 500mg tablets (HRA Pharma UK & Ireland Ltd)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
133971000001116	Lysodren 500mg tablets (HRA Pharma UK & Ireland Ltd)	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
133981000001119	Lysodren 500mg tablets (HRA Pharma UK & Ireland Ltd) (product)	en	Fully specified name	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
30922501000001118	Lysodren 500mg tablets (Laboratoire HRA Pharma) (product)	en	Fully specified name	Inactive	Only initial character case insensitive	SNOMED CT United Kingdom drug extension module
30922601000001119	Lysodren 500mg tablets (Laboratoire HRA Pharma)	en	Synonym	Inactive	Only initial character case insensitive	SNOMED CT United Kingdom drug extension module
56833701000001110	Lysodren 500mg tablets (HRA Pharma UK Ltd)	en	Synonym	Inactive	Entire term case sensitive	SNOMED CT United Kingdom drug extension module